Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Depreciation & Amortization (CF) (2016 - 2025)

Bruker's Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $58.1 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 9.83% year-over-year to $58.1 million; the TTM value through Dec 2025 reached $220.3 million, up 19.92%, while the annual FY2025 figure was $220.3 million, 19.86% up from the prior year.
  • Depreciation & Amortization (CF) reached $58.1 million in Q4 2025 per BRKRP's latest filing, up from $55.7 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $58.1 million in Q4 2025 to a low of $21.0 million in Q3 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $34.8 million, with a median of $26.2 million recorded in 2023.
  • Peak YoY movement for Depreciation & Amortization (CF): dropped 5.41% in 2022, then soared 91.73% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $23.0 million in 2021, then grew by 6.52% to $24.5 million in 2022, then surged by 52.24% to $37.3 million in 2023, then skyrocketed by 41.82% to $52.9 million in 2024, then rose by 9.83% to $58.1 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Depreciation & Amortization (CF) are $58.1 million (Q4 2025), $55.7 million (Q3 2025), and $56.1 million (Q2 2025).